Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGN-214868 repeat-treatment study in postherpetic neuralgia
2010-020977-18Phase 2Completed
- Sponsor
- Allergan
- Start
- Jul 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing AGN-214868 with Placebo (2 arms). Primary endpoints: Change from baseline in average pain intensity at Week 12 after treatment 1, Pharmacokinetics of AGN-214868 and 2 more. Started Jul 2010; status: completed.
02
Drugs
senrebotase
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on 2010-020977-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020977-18.